Needle Exchange Policy

American Liver Foundation position on needle exchange

  • WHEREAS injection drug users that share needles are at increased risk of contracting hepatitis B, hepatitis C and HIV; and
  • WHEREAS HIV, hepatitis B and hepatitis C are devastating diseases and can be transmitted to sexual partners and unborn children; and
  • WHEREAS the National Academy of Sciences, through the National Research Council and Institute of Medicine, has stated that needle exchange programs are part of a comprehensive strategy to decrease the transmission of blood-borne pathogens including hepatitis and HIV:
  • THEREFORE BE IT RESOLVED that ALF supports and encourages the development and analysis of needle exchange programs for the express purpose of decreasing transmission of HIV, hepatitis and other blood-borne pathogens and as part of comprehensive hepatitis and HIV prevention activities that include programs directed at preventing and treating drug use

Last updated on August 4th, 2022 at 11:27 am

cross linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram